These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 16947009)

  • 1. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.
    Charnsangavej C; Clary B; Fong Y; Grothey A; Pawlik TM; Choti MA
    Ann Surg Oncol; 2006 Oct; 13(10):1261-8. PubMed ID: 16947009
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al.
    Chapman WC; Hoff PM; Strasberg SM
    Ann Surg Oncol; 2006 Oct; 13(10):1269-70. PubMed ID: 16952024
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving resectability of hepatic colorectal metastases: expert consensus statement.
    Abdalla EK; Adam R; Bilchik AJ; Jaeck D; Vauthey JN; Mahvi D
    Ann Surg Oncol; 2006 Oct; 13(10):1271-80. PubMed ID: 16955381
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.
    Adams RB; Haller DG; Roh MS
    Ann Surg Oncol; 2006 Oct; 13(10):1281-3. PubMed ID: 16964448
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection for hepatic resection of colorectal liver metastases: expert consensus statement.
    Adams RB; Aloia TA; Loyer E; Pawlik TM; Taouli B; Vauthey JN; ; ;
    HPB (Oxford); 2013 Feb; 15(2):91-103. PubMed ID: 23297719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical therapy of liver metastases.
    Kuvshinoff B; Fong Y
    Semin Oncol; 2007 Jun; 34(3):177-85. PubMed ID: 17560979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases.
    Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Mortensen FV; Pedersen EM
    Acta Radiol; 2020 Feb; 61(2):156-167. PubMed ID: 31189329
    [No Abstract]   [Full Text] [Related]  

  • 8. Timing of the liver resection for patients with synchronous metastases: practical and outcome considerations.
    Mansour J; Fong Y
    Ann Surg Oncol; 2007 Sep; 14(9):2435-6. PubMed ID: 17562115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer].
    Heinemann V; Löhe F
    MMW Fortschr Med; 2009 Jan; 151(5):35-7. PubMed ID: 19391410
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.
    Thomay AA; Charpentier KP
    J Surg Oncol; 2010 Dec; 102(8):1002-8. PubMed ID: 20734423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection for colorectal metastasis; time to challenge the accepted doctrine.
    Sharpe J; Hamady ZZ; Lodge JP
    Minerva Chir; 2005 Oct; 60(5):375-89. PubMed ID: 16210987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of disappearing colorectal liver metastases.
    Kuhlmann K; van Hilst J; Fisher S; Poston G
    Eur J Surg Oncol; 2016 Dec; 42(12):1798-1805. PubMed ID: 27260846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
    J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
    Welsh FK; Tekkis PP; John TG; Rees M
    Dig Surg; 2008; 25(6):406-12. PubMed ID: 19212112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When is first-line resection of hepatic metastasis indicated?].
    Chiche L;
    Gastroenterol Clin Biol; 2003 Mar; 27 Spec No 2():B11-3, B41-61. PubMed ID: 12637872
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing management of colorectal hepatic metastases: now and in the future.
    Uppal A; Weichselbaum RR; Posner MC
    Eur J Surg Oncol; 2014 Sep; 40(9):1033-5. PubMed ID: 24703655
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.
    Lim E; Thomson BN; Heinze S; Chao M; Gunawardana D; Gibbs P
    ANZ J Surg; 2007 Nov; 77(11):941-7. PubMed ID: 17931254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.